§ Mr. Skeetasked the Secretary of State for Social Services what decision he has reached regarding the maximum rate of return to be permitted to pharmaceutical companies supplying drugs to the National Health Service; what assessment he has made in reaching his decision of the future research and development requirements of those companies; and if he will make a statement.
§ Mr. Kenneth ClarkeWe are still considering the changes to be made within the pharmaceutical price regulation scheme from 1 April.